These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6989713)

  • 1. [Protein and peptide fribrinolysis inhibitor in human amniotic fluid].
    Uszyński M
    Ginekol Pol; 1980 Feb; 51(2):113-8. PubMed ID: 6989713
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight peptides with anti-thrombin and anti-urokinase activity isolated from human maternal and cord blood serum and amniotic fluid.
    Uszyński M; Beller FK
    Arch Gynakol; 1976; 221(1):5-9. PubMed ID: 989267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancy.
    Aznar J; Hernandez A; Parrilla JJ; Estelles A; Gilabert J
    Thromb Haemost; 1976 Apr; 35(2):382-5. PubMed ID: 989638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid.
    Uszyński M; Uszyński-Folejewska R
    Am J Obstet Gynecol; 1969 Dec; 105(7):1041-3. PubMed ID: 5352583
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and characterization of vitamin B12-binding proteins from human fluids.
    Kumar S; Meyer LM
    Methods Enzymol; 1980; 67():80-9. PubMed ID: 7366452
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of the components of the fibrinolytic system in the amniotic fluid].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of fibrinolysis in amniotic fluid.
    Walker JE; Campbell DM; Ogston D
    Thromb Haemost; 1980 Aug; 44(1):32-4. PubMed ID: 6968460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of proteinase inhibitors in human amniotic fluid and maternal serum.
    Bhat AR; Pattabiraman TN
    Br J Obstet Gynaecol; 1980 Dec; 87(12):1109-14. PubMed ID: 6159919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M
    Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of amniotic fluid fibrinolytic activity (author's transl)].
    Hernandez A; Parrilla JJ; Aznar J; Gilabert J; Estelles A
    Sangre (Barc); 1975; 20(2):108-12. PubMed ID: 124956
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of antifibrinolytics and heparin on the toxicity of placental, brain and amniotic fluid thromboplastins in rats.
    Koutský J; Hladovec J; Bednár B
    Acta Univ Carol Med (Praha); 1971; 17(7):477-86. PubMed ID: 5163359
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity and characterization of a low molecular fraction present in human amniotic fluid with broad spectrum antibacterial activity.
    Sachs BP; Stern CM
    Br J Obstet Gynaecol; 1979 Feb; 86(2):81-6. PubMed ID: 427056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE; Gow L; Campbell DM; Ogston D
    Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of low-molecular (dialysing) urokinase inhibitor in human placental homogenates].
    Uszyński M
    Ginekol Pol; 1977 Oct; 48(10):905-10. PubMed ID: 924218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardization of protease inhibitor from cattle organs].
    Markwardt F; Richter M
    Pharmazie; 1969 Oct; 24(10):620-2. PubMed ID: 5308773
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and some characteristics of urokinase inhibitors isolated from pig leucocytes.
    Kopitar M
    Haemostasis; 1981; 10(4):215-32. PubMed ID: 7019016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
    Estellés A; Gilabert J; Andrés C; España F; Aznar J
    Thromb Haemost; 1990 Oct; 64(2):281-5. PubMed ID: 2125378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.